Related Experiment Video

Updated: May 12, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

An update on pharmacologic approaches to bronchopulmonary dysplasia

Sailaja Ghanta1, Kristen Tropea Leeman, Helen Christou

  • 1Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Seminars in Perinatology
|April 16, 2013
PubMed

Insights

Bronchopulmonary dysplasia (BPD) is a common lung condition in extremely preterm infants. This review explores current and future pharmacotherapies to prevent and treat BPD, aiming to improve infant outcomes.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in extremely preterm infants.
  • BPD is associated with significant risks, including reactive airways disease, pulmonary hypertension, and adverse neurodevelopmental outcomes.
  • Prevalence rates are high, affecting up to 60% of infants born before 26 weeks of gestation.

Purpose of the Study:

  • To review recent advancements in the pharmacotherapy for Bronchopulmonary dysplasia (BPD).
  • To detail current research and evidence for existing and novel BPD treatments.
  • To explore potential future experimental therapies for BPD.

Main Methods:

  • Literature review of current and emerging pharmacotherapies for BPD.
  • Analysis of evidence supporting various treatment approaches.
  • Synthesis of research on the evolving understanding of BPD pathophysiology.

Main Results:

  • Approaches to BPD prevention and treatment are continuously evolving.
  • Pharmacotherapy remains a key area of research for managing BPD.
  • Understanding BPD's complex pathophysiology guides therapeutic development.

Conclusions:

  • Continued research into pharmacotherapy is crucial for managing BPD.
  • Evolving understanding of BPD pathogenesis necessitates adaptive treatment strategies.
  • Future therapies hold promise for improving outcomes in affected infants.

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: